This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

American Shared Hospital Services Shares News That World’s First MEVION S250 Proton Therapy Treatment Has Been Delivered At Barnes-Jewish Hospital

AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today shared an announcement from Mevion Medical Systems, developer of the MEVION S250 Proton Therapy System for cancer treatment, that the world’s first MEVION S250 proton therapy treatment has been delivered to a patient at Barnes-Jewish Hospital in St. Louis.

AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D., said, "Treatment of the first patient on the MEVION S250 Proton Therapy System is a major step in increasing the availability of this cutting-edge cancer fighting technology. Until now, widespread adoption of proton therapy has been limited by the high capital and operating costs of conventional systems. Because of its significantly lower capital and operating costs, we believe many leading cancer centers will now consider providing proton therapy with the MEVION S250 system. AMS’s proven financing model can help make this happen. AMS’ first MEVION S250 system is under installation at Orlando Health in Orlando, FL. We currently have commitments for two additional MEVION S250 systems and anticipate that we will place many more orders."

AMS owns an equity interest in Mevion, and will supply a MEVION S250 for the proton center now under construction at Orlando Health, in addition to other projects under development:

World’s First MEVION S250 Proton Therapy Treatment Delivered at Barnes-Jewish Hospital

Landmark event represents a new era in radiation therapy.

ST. LOUIS, M.O., December 19, 2013 -- A patient with a rare type of cancer called chondrosarcoma at the base of the skull has become the first person in the world to receive proton therapy using the revolutionary MEVION S250 Proton Therapy System from Mevion Medical Systems, Inc. of Littleton, MA. Radiation oncologists at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis delivered the treatment. The S. Lee Kling Proton Therapy Center at Barnes-Jewish Hospital is home to the MEVION S250, a unique proton therapy device designed to deliver the same precise, non-invasive treatments delivered by conventional proton systems but with a greatly reduced physical footprint, streamlined clinical workflow, and significantly lower implementation and operational costs.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs